GlaxoSmithKline fined for misleading Ribena ads

Global drugs and health drinks company GlaxoSmithKline has been fined in New Zealand for misleading advertising after two science students found its iconic blackcurrant drink Ribena contained no detectable vitamin C.

GlaxoSmithKline fined for misleading Ribena ads

Global drugs and health drinks company GlaxoSmithKline has been fined in New Zealand for misleading advertising after two science students found its iconic blackcurrant drink Ribena contained no detectable vitamin C.

The multinational company admitted to 15 charges of misleading advertising between 2002 and 2006 in a suit filed by the Commerce Commission, a consumer watchdog, after a 2004 school science project exposed the false claims.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited